Home › Funds › PDS Planning, Inc › ABT

PDS Planning, Inc position in ABT

ABBOTT LABORATORIES · Health Care

PDS Planning, Inc reported holding 108,716 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$10.7M, representing 0.61% of its reported portfolio and ranking #34 among its reported holdings. PDS Planning, Inc has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)108.72K sh
Reported value held$10.74M
Portfolio Weight0.61%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How PDS Planning, Inc's ABT position evolved

PDS Planning, Inc first disclosed a stake in ABT in Q3 2023 at 113,055 shares (US$10.9M). The position peaked in Q2 2025 at 120,786 shares, worth US$16.4M. Across 13 filings, PDS Planning, Inc increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 108,716 shares valued at US$10.7M — a reduction of -890 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 113.06K $10.95M New
Q4 2023 113.45K $12.49M Hold
Q1 2024 113.27K $12.87M Hold
Q2 2024 104.03K $10.81M Reduce
Q3 2024 115.36K $13.15M Add
Q4 2024 117.42K $13.28M Add
Q1 2025 117.32K $15.56M Hold
Q2 2025 120.79K $16.43M Add
Q3 2025 120.65K $16.16M Hold
Q4 2025 121.40K $15.21M Add
Q1 2026 119.73K $12.29M Reduce
Q2 2026 109.61K $9.95M Reduce
Q3 2026 108.72K $10.74M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has PDS Planning, Inc held ABT?

PDS Planning, Inc has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is PDS Planning, Inc's current position in ABT?

As of Q3 2026, PDS Planning, Inc holds 108.72K shares of ABT (ABBOTT LABORATORIES), valued at $10.74M, representing 0.61% of its reported portfolio and ranking #34.

Has PDS Planning, Inc been buying or selling ABT?

In the latest 13F filing (Q3 2026), PDS Planning, Inc reduced its position in ABT. The position peaked in Q2 2025 at 120.79K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.